RNA — ATRIUM THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 159 SEC-registered investment managers reported holding RNA (ATRIUM THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $213.97M across 17.38M shares. That is +15.9% by share count (+2.05M shares) versus the previous quarter, while reported value moved +19.5%. Ownership is concentrated: the five largest holders account for 37.7% of reported value and the top ten for 52.3%.
Compared with the prior quarter, 42 opened new positions, 48 added to existing stakes, 36 trimmed, 48 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ATRIUM THERAPEUTICS INC (RNA) include Wellington Management Group, Vanguard Group, Sessa Capital IM, L.P., ranked by reported 13F value among the 228 institutional holders on this page.
RNA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 94 | 5.79M | $47.96M | +10.7% |
| Q2 2026 | 159 | 17.38M | $213.97M | +15.9% |
| Q1 2026 | 165 | 16.91M | $205.39M | -50.9% |
| Q4 2025 | 9 | 4.57M | $318.14M | -78.7% |
| Q3 2025 | 7 | 21.03M | $490.15M | -2.6% |
| Q2 2025 | 8 | 21.60M | $306.74M | -3.2% |
| Q1 2025 | 7 | 22.09M | $317.76M | +9.3% |
| Q4 2024 | 9 | 20.84M | $283.89M | +4.9% |
Over the 8 quarters shown, institutional share counts decreased 72% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q4 2025 (-78.7%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.22M | $10.09M | 0.00% | Reduce | |
| 730.03K | $6.04M | 0.00% | Hold | |
| 379.82K | $3.15M | 0.00% | Reduce | |
| 321.49K | $2.66M | 0.01% | Add | |
| 311.72K | $2.58M | 1.14% | Add | |
| 291.02K | $2.41M | 0.00% | Add | |
| 200.00K | $1.66M | 0.14% | Add | |
| 178.82K | $1.48M | 0.00% | Add | |
| 178.32K | $1.48M | 0.42% | Add | |
| 150.00K | $1.24M | 0.12% | Add | |
| 116.27K | $962.74K | 0.01% | Add | |
| 113.72K | $941.63K | 0.09% | Add | |
| 112.65K | $932.76K | 0.70% | New | |
| 112.53K | $931.79K | 0.00% | Reduce | |
| 110.24K | $912.79K | 0.00% | Hold | |
| 107.97K | $894.00K | 0.51% | Hold | |
| 106.53K | $882.09K | 0.00% | New | |
| 102.95K | $852.47K | 0.00% | Add | |
| 80.11K | $663.33K | 0.00% | Add | |
| 63.75K | $527.87K | 0.00% | Reduce | |
| 61.26K | $507.19K | 0.01% | Add | |
| 59.33K | $491.23K | 0.00% | New | |
| 58.38K | $483.40K | 0.61% | Reduce | |
| 55.89K | $462.79K | 0.00% | Add | |
| 44.23K | $366.22K | 0.01% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.50M | $20.18M | 0.34% | Add | |
| 1.47M | $19.81M | 0.00% | Reduce | |
| 1.45M | $19.47M | 0.00% | Add | |
| 840.60K | $11.31M | 0.01% | Add | |
| 730.83K | $9.83M | 0.00% | Add | |
| 641.54K | $8.63M | 5.68% | New | |
| 561.53K | $7.55M | 0.37% | Reduce | |
| 386.93K | $5.21M | 0.00% | New | |
| 386.93K | $5.21M | 0.00% | Add | |
| 345.48K | $4.65M | 0.01% | Add | |
| 310.34K | $4.17M | 0.00% | Reduce | |
| 300.00K | $4.04M | 0.21% | Hold | |
| 261.29K | $3.51M | 1.79% | Add | |
| 256.92K | $3.46M | 0.10% | Add | |
| 237.64K | $3.20M | 0.92% | Add | |
| 219.73K | $2.96M | 0.05% | Reduce | |
| 200.56K | $2.70M | 0.00% | Add | |
| 200.56K | $2.70M | 0.00% | Add | |
| 199.16K | $2.68M | 0.02% | Add | |
| 172.24K | $2.32M | 0.00% | New | |
| 172.24K | $2.32M | 0.00% | New | |
| 150.03K | $2.02M | 0.14% | Hold | |
| 150.00K | $2.02M | 0.04% | Add | |
| 146.74K | $1.97M | 0.01% | Reduce | |
| 139.24K | $1.87M | 0.47% | Hold |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.55M | $20.77M | 0.00% | New | |
| 1.21M | $16.11M | 0.00% | New | |
| 864.10K | $11.55M | 0.12% | New | |
| 626.87K | $8.38M | 0.00% | New | |
| 607.55K | $8.12M | 0.43% | New | |
| 602.65K | $8.06M | 0.11% | New | |
| 578.01K | $7.73M | 0.42% | New | |
| 551.39K | $7.37M | 0.13% | New | |
| 349.95K | $4.68M | 0.00% | New | |
| 349.36K | $4.67M | 0.03% | New | |
| 349.36K | $4.67M | 0.03% | New | |
| 344.37K | $4.60M | 0.00% | New | |
| 319.83K | $4.28M | 0.00% | New | |
| 300.00K | $4.01M | 0.25% | New | |
| 263.10K | $3.52M | 0.08% | New | |
| 257.09K | $3.44M | 0.00% | New | |
| 240.70K | $3.22M | 0.09% | New | |
| 235.64K | $3.15M | 0.16% | New | |
| 235.12K | $3.14M | 0.01% | New | |
| 231.47K | $3.09M | 0.01% | New | |
| 230.00K | $3.08M | 1.79% | New | |
| 190.86K | $2.55M | 0.00% | Reduce | |
| 190.86K | $2.55M | 0.00% | New | |
| 183.58K | $2.45M | 0.00% | New | |
| 180.94K | $2.42M | 0.74% | New |
Q4 2025 — 9 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.42M | $174.21M | 0.08% | Add | |
| 1.18M | $85.23M | 0.01% | Add | |
| 723.12K | $52.16M | 0.01% | Reduce | |
| 71.63K | $5.17M | 0.02% | New | |
| 14.15K | $1.02M | 0.00% | New | |
| 13.90K | $181.95K | 0.00% | Add | |
| 1.77K | $128.03K | 0.07% | Hold | |
| 2.10K | $27.49K | 0.00% | New | |
| 142.89K | $10.31K | 0.00% | Reduce |
Q3 2025 — 7 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.07M | $438.54M | 0.08% | Add | |
| 1.12M | $48.96M | 0.01% | Add | |
| 37.52K | $1.63M | 0.00% | Reduce | |
| 11.58K | $504.41K | 0.00% | Reduce | |
| 9.79M | $426.44K | 0.05% | Reduce | |
| 1.77K | $77.34K | 0.05% | Hold | |
| 1.00K | $7.28K | 0.00% | Add |
Q2 2025 — 8 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.25M | $262.69M | 0.05% | Reduce | |
| 1.05M | $29.77M | 0.01% | Add | |
| 251.99K | $7.16M | 0.00% | Add | |
| 237.40K | $6.74M | 0.01% | New | |
| 10.81M | $306.97K | 0.04% | Reduce | |
| 1.77K | $50.41K | 0.03% | Hold | |
| 4.80K | $25.00K | 0.00% | Add | |
| 100 | $536 | 0.00% | New |
New Positions (Q2 2026)
- CRCM LP 641.54K sh · $8.63M
- GEODE CAPITAL MANAGEMENT, LLC 386.93K sh · $5.21M
- AQR Capital Management 172.24K sh · $2.32M
- AQR CAPITAL MANAGEMENT LLC 172.24K sh · $2.32M
- Sixth Street Partners Management Company, L.P. 130.22K sh · $1.75M
- DAFNA Capital Management LLC 128.00K sh · $1.72M
- Norges Bank Investment Management 126.58K sh · $1.70M
- Anson Funds Management LP 125.00K sh · $1.68M
- Trium Capital LLP 113.28K sh · $1.52M
- BlueCrest Capital Management Ltd 100.00K sh · $1.34M
- Franklin Resources 56.70K sh · $762.60K
- JACOBS LEVY EQUITY MANAGEMENT, INC 53.99K sh · $726.19K
Fully Exited (vs previous quarter)
- RA CAPITAL MANAGEMENT, L.P. sold 864.10K sh · $11.55M
- Pentwater Capital Management LP sold 602.65K sh · $8.06M
- O'Connor Alternative Investments LLC sold 578.01K sh · $7.73M
- Farallon Capital Management sold 349.36K sh · $4.67M
- FARALLON CAPITAL MANAGEMENT, L.L.C. sold 349.36K sh · $4.67M
- Bellevue Group AG sold 263.10K sh · $3.52M
- STATE STREET CORP sold 257.09K sh · $3.44M
- AQR Arbitrage LLC sold 179.71K sh · $2.40M
- Janus Henderson Group sold 139.97K sh · $1.87M
- Neuberger Berman Group LLC sold 69.29K sh · $926.46K
- Quarry LP sold 66.65K sh · $891.12K
- Westchester Capital Management, LLC sold 55.24K sh · $738.51K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 1.22M | 1.45M | 1.21M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 730.03K | 730.83K | 626.87K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 379.82K | 386.93K | 319.83K | — | — | — | — | — | — | — | — | — | — | 1.44M | 1.30M | — | 939.62K | 848.70K | 737.10K | 714.24K |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 321.49K | 31.48K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Arbiter Partners Capital Management LLC | 311.72K | 261.29K | 230.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 291.02K | — | 257.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlueCrest Capital Management Ltd | 200.00K | 100.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Quantinno Capital Management LP | 178.82K | 27.42K | 12.45K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Yakira Capital Management, Inc. | 178.32K | 133.05K | 126.64K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| AWM Investment Company, Inc. | 150.00K | 107.50K | 50.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Groupe la Francaise | 116.27K | 80.27K | 29.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CREDIT INDUSTRIEL ET COMMERCIAL | 113.72K | 89.72K | 23.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Kalehua Capital Management LLC | 112.65K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Squarepoint Ops LLC | 112.53K | 146.74K | 231.47K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 110.24K | 109.96K | 95.13K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Athos Capital Ltd | 107.97K | 107.97K | 107.97K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Qube Research & Technologies Ltd | 106.53K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 102.95K | 101.19K | 344.37K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 80.11K | 41.94K | 165.04K | — | — | — | — | — | — | — | — | — | — | 1.10M | 1.25M | 1.02M | 80.58K | 134.23K | 109.37K | 74.82K |
| JANE STREET GROUP, LLC | 63.75K | 109.81K | 19.95K | — | — | — | — | — | — | 15.00K | 81.80K | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold RNA?
As of 2026-Q2, 159 institutional funds reported holding RNA (ATRIUM THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $213.97M.
How many shares of RNA do institutions own?
13F filers reported 17.38M shares of RNA, worth $213.97M in aggregate at the end of 2026-Q2.
Is institutional ownership of RNA rising or falling?
Share counts moved +15.9% versus the prior quarter — accumulation.
Who are the top institutional holders of RNA?
The largest 13F holders are Wellington Management Group, Vanguard Group, Sessa Capital IM, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Alkeon Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of ATRIUM THERAPEUTICS INC?
The major shareholders of ATRIUM THERAPEUTICS INC (RNA) by reported 13F value are Wellington Management Group, Vanguard Group, Sessa Capital IM, L.P., PRICE T ROWE ASSOCIATES INC /MD/, Alkeon Capital Management, among 228 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.